Developmental expression of the neuron-specific N- acetylglucosaminyltransferase Vb (GnT-Vb/IX) and identification of its in Vivo glycan products in comparison with those of its paralog, GnT-V

Journal of Biological Chemistry

Volumn 287, Issue 34, 2012, Pages 28526-28536

  Lee, Jin Kyu ^a   Matthews, Russell T ^b   Lim, Jae Min ^a,c   Swanier, Kiara ^a   Wells, Lance ^a   Pierce, J Michael ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c Changwon National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCANS; GLYCOSYL TRANSFERASE; GLYCOSYLTRANSFERASES; IN-VITRO; IN-VIVO; LAMININ; LOW LEVEL; MUSCULAR DYSTROPHY; N-LINKED; N-LINKED GLYCANS; NEURAL TISSUE; O-LINKED; PARALOGS; TOTAL LOSS;

HISTOLOGY; TISSUE;

MAMMALS;

ALPHA 1,3(6) MANNOSYLGLYCOPROTEIN BETA 1,6 N ACETYLGLUCOSAMINYLTRANSFERASE; ALPHA DYSTROGLYCAN; BETA 1,6 GLUCAN; GLYCAN; LAMININ; N ACETYLGLUCOSAMINYLTRANSFERASE; N ACETYLGLUCOSAMINYLTRANSFERASE VB; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN TISSUE; CARBOHYDRATE ANALYSIS; CARBOHYDRATE SYNTHESIS; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME GLYCOSYLATION; ENZYME MECHANISM; GENE DISRUPTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARALOGY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

ANIMALS; BRAIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOSYLATION; HUMANS; MICE; MICE, KNOCKOUT; MUSCULAR DYSTROPHIES; N-ACETYLGLUCOSAMINYLTRANSFERASES; NERVE TISSUE PROTEINS; POLYSACCHARIDES;

EID: 84865229984     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.367565     Document Type: Article

References (74)

1. Dobyns, W. B., Kirkpatrick, J. B., Hittner, H. M., Roberts, R. M., and Kretzer, F. L. (1985) Syndromes with lissencephaly. II. Walker-Warburg and cerebro-oculo-muscular syndromes and a new syndrome with type II lissencephaly. Am. J. Med. Genet. 22, 157-195 (Pubitemid 15243635)
2. Golden, J. A. (2001) Cell migration and cerebral cortical development. Neuropathol. Appl. Neurobiol. 27, 22-28
3. Haltia, M., Leivo, I., Somer, H., Pihko, H., Paetau, A., Kivelä, T., Tarkkanen, A., Tom, F., Engvall, E., and Santavuori, P. (1997) Muscle-eye-brain disease. A neuropathological study. Ann. Neurol. 41, 173-180
4. Jimenez-Mallebrera, C., Brown, S. C., Sewry, C. A., and Muntoni, F. (2005) Congenital muscular dystrophy. Molecular and cellular aspects. Cell. Mol. Life Sci. 62, 809-823 (Pubitemid 40655631)
5. Lian, G., and Sheen, V. (2006) Cerebral developmental disorders. Curr. Opin. Pediatr. 18, 614-620 (Pubitemid 44747153)
6. Parano, E., Pavone, L., Fiumara, A., Falsaperla, R., Trifiletti, R. R., and Dobyns, W. B. (1995) Congenital muscular dystrophies. Clinical review and proposed classification. Pediatr. Neurol. 13, 97-103
7. Ross, M. E., and Walsh, C. A. (2001) Human brain malformations and their lessons for neuronal migration. Annu. Rev. Neurosci. 24, 1041-1070 (Pubitemid 32695253)
8. van der Knaap, M. S., Smit, L. M., Barth, P. G., Catsman-Berrevoets, C. E., Brouwer, O. F., Begeer, J. H., de Coo, I. F., and Valk, J. (1997) Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities. Ann. Neurol. 42, 50-59 (Pubitemid 27304780)
9. Grewal, P. K., Holzfeind, P. J., Bittner, R. E., and Hewitt, J. E. (2001) Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse. Nat. Genet. 28, 151-154 (Pubitemid 32538060)
10. Michele, D. E., Barresi, R., Kanagawa, M., Saito, F., Cohn, R. D., Satz, J. S., Dollar, J., Nishino, I., Kelley, R. I., Somer, H., Straub, V., Mathews, K. D., Moore, S. A., and Campbell, K. P. (2002) Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418, 417-422 (Pubitemid 34826841)
11. Takeda, S., Kondo, M., Sasaki, J., Kurahashi, H., Kano, H., Arai, K., Misaki, K., Fukui, T., Kobayashi, K., Tachikawa, M., Imamura, M., Nakamura, Y., Shimizu, T., Murakami, T., Sunada, Y., Fujikado, T., Matsumura, K., Terashima, T., and Toda, T. (2003) Fukutin is required for maintenance of muscle integrity, cortical histogenesis, and normal eye development. Hum. Mol. Genet. 12, 1449-1459 (Pubitemid 36758457)
12. Chai, W., Yuen, C. T., Kogelberg, H., Carruthers, R. A., Margolis, R. U., Feizi, T., and Lawson, A. M. (1999) High prevalence of 2-mono- and 2,6- di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. Eur. J. Biochem. 263, 879-888 (Pubitemid 29361963)
13. Finne, J., Krusius, T., Margolis, R. K., and Margolis, R. U. (1979) Novel mannitol-containing oligosaccharides obtained by mild alkaline borohydride treatment of a chondroitin sulfate proteoglycan from brain. J. Biol. Chem. 254, 10295-10300
14. Kogelberg, H., Chai, W., Feizi, T., and Lawson, A. M. (2001) NMR studies of mannitol-terminating oligosaccharides derived by reductive alkaline hydrolysis from brain glycoproteins. Carbohydr. Res. 331, 393-401 (Pubitemid 32452183)
15. Krusius, T., Finne, J., Margolis, R. K., and Margolis, R. U. (1986) Identification of an O-glycosidic mannose-linked sialylated tetrasaccharide and keratan sulfate oligosaccharides in the chondroitin sulfate proteoglycan of brain. J. Biol. Chem. 261, 8237-8242 (Pubitemid 17202694)
16. Beltrán-Valero de Bernabé, D., Currier, S., Steinbrecher, A., Celli, J., van Beusekom, E., van der Zwaag, B., Kayserili, H., Merlini, L., Chitayat, D., Dobyns, W. B., Cormand, B., Lehesjoki, A. E., Cruces, J., Voit, T., Walsh, C. A., van Bokhoven, H., and Brunner, H. G. (2002) Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am. J. Hum. Genet. 71, 1033-1043
17. Beltran-Valero de Bernabé, D., Voit, T., Longman, C., Steinbrecher, A., Straub, V., Yuva, Y., Herrmann, R., Sperner, J., Korenke, C., Diesen, C., Dobyns, W. B., Brunner, H. G., van Bokhoven, H., Brockington, M., and Muntoni, F. (2004) Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome. J. Med. Genet. 41, e61
18. Brockington, M., Blake, D. J., Prandini, P., Brown, S. C., Torelli, S., Benson, M. A., Ponting, C. P., Estournet, B., Romero, N. B., Mercuri, E., Voit, T., Sewry, C. A., Guicheney, P., and Muntoni, F. (2001) Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan. Am. J. Hum. Genet. 69, 1198-1209 (Pubitemid 33124201)
19. Brockington, M., Yuva, Y., Prandini, P., Brown, S. C., Torelli, S., Benson, M. A., Herrmann, R., Anderson, L. V., Bashir, R., Burgunder, J. M., Fallet, S., Romero, N., Fardeau, M., Straub, V., Storey, G., Pollitt, C., Richard, I., Sewry, C. A., Bushby, K., Voit, T., Blake, D. J., and Muntoni, F. (2001) Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum. Mol. Genet. 10, 2851-2859 (Pubitemid 34030916)
20. Currier, S. C., Lee, C. K., Chang, B. S., Bodell, A. L., Pai, G. S., Job, L., Lagae, L. G., Al-Gazali, L. I., Eyaid, W. M., Enns, G., Dobyns, W. B., and Walsh, C. A. (2005) Mutations in POMT1 are found in a minority of patients with Walker-Warburg syndrome. Am. J. Med. Genet. A 133, 53-57 (Pubitemid 40175565)
21. de Bernabé, D. B., van Bokhoven, H., van Beusekom, E., Van den Akker, W., Kant, S., Dobyns, W. B., Cormand, B., Currier, S., Hamel, B., Talim, B., Topaloglu, H., and Brunner, H. G. (2003) A homozygous nonsense mutation in the fukutin gene causes a Walker-Warburg syndrome phenotype. J. Med. Genet. 40, 845-848
22. Kobayashi, K., Nakahori, Y., Miyake, M., Matsumura, K., Kondo-Iida, E., Nomura, Y., Segawa, M., Yoshioka, M., Saito, K., Osawa, M., Hamano, K., Sakakihara, Y., Nonaka, I., Nakagome, Y., Kanazawa, I., Nakamura, Y., Tokunaga, K., and Toda, T. (1998) An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394, 388-392 (Pubitemid 28373837)
23. Longman, C., Brockington, M., Torelli, S., Jimenez-Mallebrera, C., Kennedy, C., Khalil, N., Feng, L., Saran, R. K., Voit, T., Merlini, L., Sewry, C. A., Brown, S. C., and Muntoni, F. (2003) Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of α-dystroglycan. Hum. Mol. Genet. 12, 2853-2861 (Pubitemid 37407122)
24. van Reeuwijk, J., Brunner, H. G., and van Bokhoven, H. (2005) Glyc-Ogenetics of Walker-Warburg syndrome. Clin. Genet. 67, 281-289
25. Yoshida, A., Kobayashi, K., Manya, H., Taniguchi, K., Kano, H., Mizuno, M., Inazu, T., Mitsuhashi, H., Takahashi, S., Takeuchi, M., Herrmann, R., Straub, V., Talim, B., Voit, T., Topaloglu, H., Toda, T., and Endo, T. (2001) Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev. Cell 1, 717-724 (Pubitemid 33586123)
26. Inamori, K., Yoshida-Moriguchi, T., Hara, Y., Anderson, M. E., Yu, L., and Campbell, K. P. (2012) Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Science 335, 93-96
27. Akasaka-Manya, K., Manya, H., Nakajima, A., Kawakita, M., and Endo, T. (2006) Physical and functional association of human protein O- mannosyltransferases 1 and 2. J. Biol. Chem. 281, 19339-19345 (Pubitemid 44035439)
28. Manya, H., and Endo, T. (2004) Defective O-mannosyl glycosylation causes congenital muscular dystrophies. Tanpakushitsu Kakusan Koso. 49, 2451-2456
29. Zhang, W., Betel, D., and Schachter, H. (2002) Cloning and expression of a novel UDP-GlcNAc:α-D-mannoside β1,2-N-acetylglucosaminyltransferase homologous to UDP-GlcNAc:α-3-D-mannoside β1,2-N- acetylglucosaminyltransferase I. Biochem. J. 361, 153-162 (Pubitemid 34171420)
30. Yoshida-Moriguchi, T., Yu, L., Stalnaker, S. H., Davis, S., Kunz, S., Madson, M., Oldstone, M. B., Schachter, H., Wells, L., and Campbell, K. P. (2010) O-Mannosyl phosphorylation of α-dystroglycan is required for laminin binding. Science 327, 88-92
31. Ervasti, J. M., and Campbell, K. P. (1991) Membrane organization of the dystrophin-glycoprotein complex. Cell 66, 1121-1131 (Pubitemid 121001402)
32. Ervasti, J. M., and Campbell, K. P. (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122, 809-823 (Pubitemid 23241091)
33. Ibraghimov-Beskrovnaya, O., Ervasti, J. M., Leveille, C. J., Slaughter, C. A., Sernett, S. W., and Campbell, K. P. (1992) Primary structure of dystrophin- associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355, 696-702
34. Winder, S. J. (2001) The complexities of dystroglycan. Trends Biochem. Sci. 26, 118-124
35. Gee, S. H., Blacher, R. W., Douville, P. J., Provost, P. R., Yurchenco, P. D., and Carbonetto, S. (1993) Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. J. Biol. Chem. 268, 14972-14980 (Pubitemid 23206646)
36. Montanaro, F., Lindenbaum, M., and Carbonetto, S. (1999) α-Dystroglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability. J. Cell Biol. 145, 1325-1340
37. Smalheiser, N. R., and Kim, E. (1995) Purification of cranin, a lamininbinding membrane protein. Identity with dystroglycan and reassessment of its carbohydrate moieties. J. Biol. Chem. 270, 15425-15433
38. Yamada, H., Shimizu, T., Tanaka, T., Campbell, K. P., and Matsumura, K. (1994) Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS Lett. 352, 49-53 (Pubitemid 24291757)
39. Chiba, A., Matsumura, K., Yamada, H., Inazu, T., Shimizu, T., Kusunoki, S., Kanazawa, I., Kobata, A., and Endo, T. (1997) Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve α-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of α-dystroglycan with laminin. J. Biol. Chem. 272, 2156-2162 (Pubitemid 27058494)
40. Sasaki, T., Yamada, H., Matsumura, K., Shimizu, T., Kobata, A., and Endo, T. (1998) Detection of O-mannosyl glycans in rabbit skeletal muscle α-dystroglycan, Biochim. Biophys. Acta 1425, 599-606 (Pubitemid 28546694)
41. Smalheiser, N. R., Haslam, S. M., Sutton-Smith, M., Morris, H. R., and Dell, A. (1998) Structural analysis of sequences O-linked to mannose reveals a novel Lewis X structure in cranin (dystroglycan) purified from sheep brain. J. Biol. Chem. 273, 23698-23703 (Pubitemid 28435699)
42. Stalnaker, S. H., Hashmi, S., Lim, J. M., Aoki, K., Porterfield, M., Gutierrez- Sanchez, G., Wheeler, J., Ervasti, J. M., Bergmann, C., Tiemeyer, M., and Wells, L. (2010) Site mapping and characterization of O-glycan structures on α-dystroglycan isolated from rabbit skeletal muscle. J. Biol. Chem. 285, 24882-24891
43. Nilsson, J., Nilsson, J., Larson, G., and Grahn, A. (2010) Characterization of site-specific O-glycan structures within the mucin-like domain of α-dystroglycan from human skeletal muscle. Glycobiology 20, 1160-1169
44. Kano, H., Kobayashi, K., Herrmann, R., Tachikawa, M., Manya, H., Nishino, I., Nonaka, I., Straub, V., Talim, B., Voit, T., Topaloglu, H., Endo, T., Yoshikawa, H., and Toda, T. (2002) Deficiency of α-dystroglycan in muscle-eye-brain disease. Biochem. Biophys. Res. Commun. 291, 1283-1286
45. Kim, D. S., Hayashi, Y. K., Matsumoto, H., Ogawa, M., Noguchi, S., Murakami, N., Sakuta, R., Mochizuki, M., Michele, D. E., Campbell, K. P., Nonaka, I., and Nishino, I. (2004) POMT1 mutation results in defective glycosylation and loss of laminin-binding activity in α-DG. Neurology 62, 1009-1011 (Pubitemid 38435801)
46. Liu, J., Ball, S. L., Yang, Y., Mei, P., Zhang, L., Shi, H., Kaminski, H. J., Lemmon, V. P., and Hu, H. (2006) A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1). Mech. Dev. 123, 228-240
47. Stalnaker, S. H., Aoki, K., Lim, J. M., Porterfield, M., Liu, M., Satz, J. S., Buskirk, S., Xiong, Y., Zhang, P., Campbell, K. P., Hu, H., Live, D., Tiemeyer, M., and Wells, L. (2011) Glycomic analyses of mouse models of congenital muscular dystrophy. J. Biol. Chem. 286, 21180-21190
48. Abbott, K. L., Matthews, R. T., and Pierce, M. (2008) Receptor tyrosine phosphatase beta (RPTPβ) activity and signaling are attenuated by glycosylation and subsequent cell surface galectin-1 binding. J. Biol. Chem. 283, 33026-33035
49. Inamori, K., Mita, S., Gu, J., Mizuno-Horikawa, Y., Miyoshi, E., Dennis, J. W., and Taniguchi, N. (2006) Demonstration of the expression and the enzymatic activity of N-acetylglucosaminyltransferase IX in the mouse brain. Biochim. Biophys. Acta 1760, 678-684
50. Kaneko, M., Alvarez-Manilla, G., Kamar, M., Lee, I., Lee, J. K., Troupe, K., Zhang, W., Osawa, M., and Pierce, M. (2003) A novel β(1,6)-N- acetylglucosaminyltransferase V (GnT-VB). FEBS Lett. 554, 515-519
51. Abbott, K. L., Troupe, K., Lee, I., and Pierce, M. (2006) Integrin-dependent neuroblastoma cell adhesion and migration on laminin is regulated by expression levels of two enzymes in the O-mannosyl-linked glycosylation pathway, PomGnT1 and GnT-Vb. Exp. Cell Res. 312, 2837-2850
52. Alvarez-Manilla, G., Troupe, K., Fleming, M., Martinez-Uribe, E., and Pierce, M. (2010) Comparison of the substrate specificities and catalytic properties of the sister N-acetylglucosaminyltransferases, GnT-V and GnT-Vb (IX). Glycobiology 20, 166-174
53. Lee, I., Guo, H. B., Kamar, M., Abbott, K., Troupe, K., Lee, J. K., Alvarez- Manilla, G., and Pierce, M. (2006) N-Acetylglucosaminyltransferase VB expression enhances β1 integrin-dependent PC12 neurite outgrowth on laminin and collagen. J. Neurochem. 97, 947-956
54. Aoki, K., Perlman, M., Lim, J. M., Cantu, R., Wells, L., and Tiemeyer, M. (2007) Dynamic developmental elaboration of N-linked glycan complexity in the Drosophila melanogaster embryo. J. Biol. Chem. 282, 9127-9142 (Pubitemid 47093502)
55. Abbott, K. L., Aoki, K., Lim, J. M., Porterfield, M., Johnson, R., O'Regan, R. M., Wells, L., Tiemeyer, M., and Pierce, M. (2008) Targeted glycoproteomic identification of biomarkers for human breast carcinoma. J. Proteome Res. 7, 1470-1480
56. Ciucanu, I. (2006) Per-O-methylation reaction for structural analysis of carbohydrates by mass spectrometry. Anal. Chim. Acta 576, 147-155
57. Kizuka, Y., Kitazume, S., Yoshida, M., and Taniguchi, N. (2011) Brainspecific expression of N-acetylglucosaminyltransferase IX (GnT-IX) is regulated by epigenetic histone modifications. J. Biol. Chem. 286, 31875-31884
58. Li, X., Zhang, P., Yang, Y., Xiong, Y., Qi, Y., and Hu, H. (2008) Differentiation and developmental origin of cerebellar granule neuron ectopia in protein O-mannose UDP-N-acetylglucosaminyltransferase 1 knock-out mice. Neuroscience 152, 391-406
59. Yang, Y., Zhang, P., Xiong, Y., Li, X., Qi, Y., and Hu, H. (2007) Ectopia of meningeal fibroblasts and reactive gliosis in the cerebral cortex of the mouse model of muscle-eye-brain disease. J. Comp. Neurol. 505, 459-477
60. Hu, H., Yang, Y., Eade, A., Xiong, Y., and Qi, Y. (2007) Breaches of the pial basement membrane and disappearance of the glia limitans during development underlie the cortical lamination defect in the mouse model of muscle-eye-brain disease. J. Comp. Neurol. 501, 168-183 (Pubitemid 46155877)
61. Hu, H., Li, J., Gagen, C. S., Gray, N. W., Zhang, Z., Qi, Y., and Zhang, P. (2011) Conditional knock-out of protein O-mannosyltransferase 2 reveals tissue-specific roles of O-mannosyl glycosylation in brain development. J. Comp. Neurol. 519, 1320-1337
62. Williamson, R. A., Henry, M. D., Daniels, K. J., Hrstka, R. F., Lee, J. C., Sunada, Y., Ibraghimov-Beskrovnaya, O., and Campbell, K. P. (1997) Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum. Mol. Genet. 6, 831-841 (Pubitemid 27239066)
63. Moore, S. A., Saito, F., Chen, J., Michele, D. E., Henry, M. D., Messing, A., Cohn, R. D., Ross-Barta, S. E., Westra, S., Williamson, R. A., Hoshi, T., and Campbell, K. P. (2002) Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 418, 422-425 (Pubitemid 34826842)
64. Satz, J. S., Barresi, R., Durbeej, M., Willer, T., Turner, A., Moore, S. A., and Campbell, K. P. (2008) Brain and eye malformations resembling Walker- Warburg syndrome are recapitulated in mice by dystroglycan deletion in the epiblast. J. Neurosci. 28, 10567-10575
65. Han, R., Kanagawa, M., Yoshida-Moriguchi, T., Rader, E. P., Ng, R. A., Michele, D. E., Muirhead, D. E., Kunz, S., Moore, S. A., Iannaccone, S. T., Miyake, K., McNeil, P. L., Mayer, U., Oldstone, M. B., Faulkner, J. A., and Campbell, K. P. (2009) Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of α-dystroglycan. Proc. Natl. Acad. Sci. U.S.A. 106, 12573-12579
66. Hu, H., Candiello, J., Zhang, P., Ball, S. L., Cameron, D. A., and Halfter, W. (2010) Retinal ectopias and mechanically weakened basement membrane in a mouse model of muscle-eye-brain (MEB) disease congenital muscular dystrophy. Mol. Vis. 16, 1415-1428
67. Chan, Y. M., Keramaris-Vrantsis, E., Lidov, H. G., Norton, J. H., Zinchenko, N., Gruber, H. E., Thresher, R., Blake, D. J., Ashar, J., Rosenfeld, J., and Lu, Q. L. (2010) Fukutin-related protein is essential for mouse muscle, brain, and eye development, and mutation recapitulates the wide clinical spectrums of dystroglycanopathies. Hum. Mol. Genet. 19, 3995-4006
68. Willer, T., Prados, B., Falcón-Pérez, J. M., Renner-Müller, I., Przemeck, G. K., Lommel, M., Coloma, A., Valero, M. C., de Angelis, M. H., Tanner, W., Wolf, E., Strahl, S., and Cruces, J. (2004) Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality. Proc. Natl. Acad. Sci. U.S.A. 101, 14126-14131 (Pubitemid 39305041)
69. Kurahashi, H., Taniguchi, M., Meno, C., Taniguchi, Y., Takeda, S., Horie, M., Otani, H., and Toda, T. (2005) Basement membrane fragility underlies embryonic lethality in fukutin-null mice. Neurobiol. Dis. 19, 208-217 (Pubitemid 40544738)
70. Dennis, J. W., and Laferté, S. (1989) Oncodevelopmental expression of -GlcNAcβ1-6Manα1-6Manβ1-branched asparagine-linked oligosaccharides in murine tissues and human breast carcinomas. Cancer Res. 49, 945-950
71. Demetriou, M., Granovsky, M., Quaggin, S., and Dennis, J. W. (2001) Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409, 733-739 (Pubitemid 32144520)
72. Guo, H. B., Lee, I., Bryan, B. T., and Pierce, M. (2005) Deletion of Mouse Embryo Fibroblast N-acetylglucosaminyltransferase V stimulates α5β1 integrin expression mediated by the protein kinase C signaling pathway. J. Biol. Chem. 280, 8332-8342 (Pubitemid 40349736)
73. Guo, H. B., Lee, I., Kamar, M., and Pierce, M. (2003) N-Acetylglucosaminyltransferase V expression levels regulate cadherin-associated homotypic cell-cell adhesion and intracellular signaling pathways. J. Biol. Chem. 278, 52412-52424 (Pubitemid 38035833)
74. Harroch, S., Furtado, G. C., Brueck, W., Rosenbluth, J., Lafaille, J., Chao, M., Buxbaum, J. D., and Schlessinger, J. (2002) A critical role for the protein- tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions. Nat. Genet. 32, 411-414 (Pubitemid 35266117)